Gene · 28923
Papers1,286
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,286
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity. | bioRxiv | 2026 | 42620328 | PubTator, text mining | PubMed |
| Programmable One-Tube Sialic Acid Derivatization Enables Dual-Mode N-Glycomics of Low-Input Samples. | Anal Chem | 2026 | 42578856 | PubTator, text mining | PubMed |
| Sialic Acid Linkage-Specific Alkylamidation-Based Method for N- and O-Glycoproteomic Profiling of Human Plasma. | Anal Chem | 2026 | 42421262 | PubTator, text mining | PubMed |
| Bioorthogonal labeling of sialic acid isomers for detection of glycoconjugates by mass spectrometry imaging and microscopy. | Methods Enzymol | 2026 | 42349971 | PubTator, text mining | PubMed |
| Galacto-Oligosaccharides Reshape Mucin O-Glycan Profiles to Enhance Small Intestinal Barrier Development in Early Life. | J Agric Food Chem | 2026 | 42284521 | PubTator, text mining | PubMed |
| α2,3-Sialyltransferase (ST3Gal1) regulates endometrioid-type epithelial ovarian cancer cell migration and invasion via VEGF-R2/JAK2/STAT3 signaling cascades. | Int J Gynaecol Obstet | 2026 | 42080626 | PubTator, text mining | PubMed |
| De novo biosynthesis of 3'-sialyllactosamine in Escherichia coli via integrated metabolic and protein engineering. | Bioresour Technol | 2026 | 42013939 | PubTator, text mining | PubMed |
| Increased levels of α2-3- and α2-6-linked sialic acids during airway inflammation govern influenza A binding to peripheral airway mucins in a subtype-dependent manner. | Front Immunol | 2026 | 41909675 | PubTator, text mining | PubMed |
| Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer. | Cell Rep Med | 2026 | 41850238 | PubTator, text mining | PubMed |
| Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression. | Front Immunol | 2026 | 41789075 | PubTator, text mining | PubMed |
| Identification of CD164 as an essential entry receptor for divergent adeno-associated viruses. | Proc Natl Acad Sci U S A | 2026 | 41785320 | PubTator, text mining | PubMed |
| FUT1- and GAL3ST2-mediated cellular glycan remodeling broadly restricts sialic acid-dependent viral infections. | Proc Natl Acad Sci U S A | 2026 | 41774787 | PubTator, text mining | PubMed |
| Fatal human H3N8 influenza virus has a moderate pandemic risk. | PLoS Pathog | 2026 | 41774777 | PubTator, text mining | PubMed |
| Global evolutionary landscape of H11 avian influenza and initial isolates identified in Xinjiang, China. | Emerg Microbes Infect | 2026 | 41770598 | PubTator, text mining | PubMed |
| Fcer1g and St3gal1: Macrophage-associated angiogenesis biomarkers and therapeutic targets in sepsis-induced acute lung injury. | PLoS One | 2026 | 41758834 | PubTator, text mining | PubMed |
| The Role of Glycan Structures in Modulating GM-CSF Bioactivity: Insights from Glycoengineering. | bioRxiv | 2026 | 41756846 | PubTator, text mining | PubMed |
| Antigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients by Multiple TLC Overlay Assay and IR-MALDI Mass Spectrometry. | Cancers (Basel) | 2026 | 41749917 | PubTator, text mining | PubMed |
| Acute haemorrhagic conjunctivitis outbreak attributed to coxsackievirus A24 in Ratanakiri, Cambodia, 2023. | Western Pac Surveill Response J | 2026 | 41743334 | PubTator, text mining | PubMed |
| Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses isolated from felines in South Korea, 2023. | Virulence | 2026 | 41725526 | PubTator, text mining | PubMed |
| Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges. | Anal Chem | 2026 | 41712472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28923/papers